Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Biomarker Identification and Nutritional Intervention of Primary Sarcopenia Based on Gut-muscle Axis

Authors not listed

Peking Union Medical College Hospital · 2024

Abstract

The loss of skeletal muscle mass and function usually occurs with aging, known as primary sarcopenia. Sarcopenia has a prevalence of 11.6% among the elderly population in China and is closely associated with increased risks of falls, disability, and mortality. Currently, there is a lack of definition criteria for sarcopenia based on biomarkers. The Gut-Muscle Axis hypothesis suggests a complex interplay between gut microbiota and skeletal muscle. Nutritional intervention targeting the gut microbiota potentially plays a significant role in muscle regeneration. Therefore, this study aims to explore the effects of symbiotic and whey protein on muscle, gut microbiota, and clinical outcomes among sarcopenia patients, to provide a reference for further diagnosis and treatment of sarcopenia.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-30 MST

Cite this

APA
Anonymous. (2024). Biomarker Identification and Nutritional Intervention of Primary Sarcopenia Based on Gut-muscle Axis. <em>Peking Union Medical College Hospital</em>. https://clinicaltrials.gov/study/NCT06347835
Vancouver
Anonymous. Biomarker Identification and Nutritional Intervention of Primary Sarcopenia Based on Gut-muscle Axis. Peking Union Medical College Hospital. 2024.
BibTeX
@misc{anon2024Biomar, title = {Biomarker Identification and Nutritional Intervention of Primary Sarcopenia Based on Gut-muscle Axis}, author = {Anonymous}, journal = {Peking Union Medical College Hospital}, year = {2024}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings